Good afternoon, and welcome to BFF Banking Group first nine months 2026 earnings call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be the opportunity to ask questions. To ask a question, you may press star then one on a touchtone phone. To withdraw your question, please press star then two. Please note, this event is being recorded. I would like to turn the conference over to Caterina Della Mora, Head of Investor Relations, Giuseppe Sica, Group CEO, and Luigi Lubelli, Group CFO. Please go ahead.
Good evening, and thank you for joining our nine months 2026 financial results call. Giuseppe Sica, our CEO, and Luigi Lubelli, our CFO, will lead the presentation. We will then open the call for Q&A. Let me hand over now to Giuseppe.
Thank you, Caterina, and thank you everyone for joining this call. Let's start with slide two and some key highlights. Our adjusted net profit is down both year-on-year and quarter-on-quarter due to planned balance sheet de-risking, largely deriving from the impact of the back book and negative court rulings. At the business level, Payments and Securities Services continue to perform well and represent a solid basis for long-term profitability. Profitability at our Factoring & Lending business was affected by the controlled reduction in business volumes as part of the de-risking I was referring to, as well as negative court rulings. While we have challenges in relation to our back book, we are satisfied with the progress of our front book. As Luigi will comment later, we are achieving an increasing IRR on our new business.
Thanks to the actions we have taken during Q3, our capital ratios remain above requirements despite negative organic capital generation. There will be further positive impact from the Pollen transaction in Q4 and across 2027 and 2028. Finally, we are in exclusive negotiations with Cerberus regarding a potential strategic transaction. We cannot provide any additional information at this stage. Moving now on to key financial metrics on slide three. While BFF continues to be profitable on a P&L basis, including a small adjusted net profit in Q3, the necessary balance sheet de-risking has impacted our P&L. Nine months adjusted ROE is at 19%, down from 27% in H1. Net revenues are down 5% year-on-year, and adjusted net profit is down 24% year-on-year to EUR 90 million. Factoring & Lending loans went down by 13%, allowing for the necessary RWA reduction.
This trend, combined with broadly stable liquidity, has led to a further improving loan-to-deposit ratio below 70%, 5 percentage points better than year-end 2025. Our CET1 ratio is up 130 basis points, thanks to management actions we have taken during this quarter, and is above requirement thanks to these actions. Without those, another breach would have been recorded, as already happened in 2025 year-end and in the first half 2026. Moving to the next slide. For the sake of clarity, I want to go in more detail on our adjusted net profit and the impact of calendar provisioning. As I mentioned on the previous slide, adjusted net profit is down 24% versus 2025, and this is primarily driven by the de-risking actions we have taken, as well as higher provisions and legal costs related to negative court rulings. The slide also shows the impact of calendar provisioning during the period.
BFF remains profitable in an adjusted net profit level. However, underlying capital generation is negative due to a EUR 96 million increase in calendar provisioning during the nine-month period, higher than the adjusted net profits. Further and increasingly higher calendar provisioning is expected in both 2027 and 2028, and I will go into more detail on this later. Before I hand over to Luigi on the next slide, I want to give more detail on how our profitability is impacted by tight capital ratios and back book margins by negative court rulings. Higher provisions, retrocessions, higher legal expenses together with the RWA reduction needed to respect capital ratios explain most of the reduction in pre-tax profit from EUR 161 million in nine months 2025 to EUR 123 million in nine months 2026. We face challenges from back book and from the tight capital ratios.
On the other hand, Transaction Services and the Factoring & Lending front book remain the basis on which to build upon. I will elaborate on both points in my concluding slides. Let me now hand over to Luigi.
Thank you, Giuseppe, and good evening everyone on the phone. As Giuseppe has just explained to you, the main drivers of the decrease in the pre-tax profit. Going to the components of such profit, you can see that Securities Services, Payments, and the Corporate Center remain reliable engines for the group and continue to perform well. Securities Services is a steady performer. It has pre-tax profit which were up EUR 2.7 million. On the other hand, you see a slight decline in Payments, but that relates only to a small one-off provision and primarily due to higher costs from ICT investments. So actually, the underlying is positive, and these are investments for the growth of the business. Factoring & Lending, as was already exposed by Giuseppe, is undergoing a reorientation. We now have a new head for this business line to start in October.
A review of the business is ongoing, and as mentioned, Giuseppe, there are encouraging signs on new production. Moving on to the next slide, number seven, we see the revenues. We see a fall in Factoring & Lending, which reflects the de-risking strategy that Giuseppe mentioned earlier, and I will not go into again. Conversely, we can see that non-Factoring & Lending revenues grew by 8% during the period. This was broadly evenly split between Securities Services and Payments, up EUR 6 million, and the Corporate Center, which benefited from EUR 7 million of realization gains. Our business is increasingly diversified, and factoring revenues now account for only one-third of revenues, down from 40% last year. Now let's move on to slide number eight, where we see the development of net income and the net interest income and the cost of funding.
As can be expected from the decline in Factoring & Lending volumes, the net interest income is down. On the other hand, the income from our bond portfolio is slightly higher. The Factoring & Lending yield and the cost of funding basically move in sync down. That explains, let's say, the direction downwards. There is a further decrease of 10 basis points, which essentially is due to changes in our business mix. We're observing encouraging signs in our new production, our front book. We have been and continue to actively work on improving the spread in new business, and our IRR has increased to around 7%, up from 6% in Q2, and this remains a strategic focus for us going forward. On slide number nine, we can see that fees and commissions in Transaction Services continue to grow.
We have Securities Services with a commission income that is up 8% year-on-year, thanks to strong commercial activity. By September, the number of onboarded funds has risen to 20 from 15, which was the figure we reported with the first half results. On Payments, you can see that there also has been a growth of 4%. Essentially, we've seen an entry of international acquirers into the BANCOMAT network, and we've also launched our Digital Collections platform. Factoring & Lending, lastly, has a recurring income from the management of third-party receivables. On slide number 10, we see our cost. I would like to highlight that we maintain a disciplined approach to costs, because actually, the underlying performance was stable, which is especially good if you bear in mind the fact that revenues are decreasing.
There are only two elements that explain variations, one in Factoring & Lending coming from legal expenses on court ruling, while I already made reference to the growth focus ICT investments in payment expenses. Barring those, basically, you kind of have the same amount, which is relatively stable, as I said. On slide 11, we have the evolution of deposits. Here too, we have a relative stability. What is to mention here is the exit of a single large counterparty in payment deposits. Also on Payments, I would like to make reference to the amount at the end of the nine months. It seems like a decrease compared to June, but in reality, it's just a punctual measurement at the close of the period. The average was broadly similar for the two quarters, except for the fact that during the summer, there is a smaller usage of checks.
There is some seasonality. A positive element on this slide is the fact that due to the falling Factoring & Lending loans and the essential stability of our funding, our loan-to-deposits ratio has gone down to 69%. So, page 12, we see the investments in Italian government bonds. Basically, the figures have not changed. As you know, in July, we already reported about that, but in terms of figures, it is reflected in the figures for the nine months. We sold and rebought HTC bonds. As you know, now in hindsight, we can say that it was a very well-timed transaction and enabled us to record a gain pre-tax of around EUR 62 million. Very importantly, we continue to have EUR 0.9 billion in fixed-rate bonds with a yield of around 60 basis points. This will mature in March and December next year, which gives us significant earnings upside.
As you know, rates have gone up lately, and our liquidity position allows us to tactically decide when to take advantage of attractive yields in preparation for next year's maturities. Slide number 13, you also have an indication of the spreads and the deposits. I would like to focus on this slide primarily on the development of the LCR and NSFR ratios, which are materially up versus the close of the previous year, and also significantly better than the close of Q2. It's an improvement in liquidity, and we, of course, are quite happy about that. The online deposits remain broadly stable versus September 2025 and are up compared to a year-end with no pricing action to mention. On slide 14, we can see our loan book exposure to Factoring & Lending in Italy, where both Factoring & Lending and Italy show a decrease.
Factoring now accounts for 48% of the total loan book, down from 53% a year ago, and around 50% of the full year. Our loan book is geographically diversified, and only now 35% of it comes from Italy. On slide 15, as we already mentioned, we have had portfolio management transactions which have driven a reduction in NPLs and in past due. NPLs and net past due are down by 50% and 14%, respectively. The UTPs reflect the reclassification of certain public hospitals in Poland following the Bank of Italy inspection. The NPL coverage ratio shows a minor improvement, but an improvement it is, excluding municipalities. We also see an increase in the cost of risk, and that is essentially driven by the negative court rulings.
The amount of adjusted provisions of EUR 14.9 million is in line with our expectations, although we still are to recover a significant part of the exposure that we have put back to clients on those rulings, and the court rulings which were negative. On slide 16, we elaborate on the negative court rulings. You know this is something we are emphasizing this year, in 2026, and we have continued to manage down these negative sentences. Some of that has had an impact on the overall profitability, as Giuseppe said before. Importantly, we now have collected about 1/3 of the overall amount that we have put back, and we are working to collect more. On slide 17, there we have a quick look at our CET1 ratio, which is increased by 130 basis points.
This is an interesting slide I would like to draw your attention upon, because this slide shows the impact of the positive income effect of the management transaction on this ratio. As you can see, and as Giuseppe described before, the net income alone in the quarter would have not been, I mean, in the year, sorry, would have not been able to offset the calendar provisioning impact, as well as the impacts from the Bank of Italy inspection report. With only that, we would have reached a CET1 ratio of 9.7% at the close of September, below the level of 2025.
But the combination, on one hand, on the capital of the HTC bond sale and the transaction with Pollen Street Capital, plus the initiatives that are being taken in order to reduce the RWA, have led to the 130 basis points increase that I referred to, and put us at a very good level of 11.2 percentage points, correct. The next few quarters will be impacted by the increasingly higher load of calendar provisioning, while we must note that managerial actions available to us decrease in number and likelihood of execution. Lastly, I have a slide which is a further deep dive on the compliance with our regulatory requirements, which, as I said before, was achieved thanks to the execution of some of the measures foreseen in our Capital Conservation Plan.
And of course, as I said before, without that, we would have had a breach of capital ratios, was the case at the close of 2025 and half year 2026. Just to notice a small decrease in the RWA density. Now I hand back the call to Giuseppe.
Thank you, Luigi. A few words on what we have achieved in the last three months, following what is embedded in our Capital Conservation Plan. As Luigi has already mentioned, the sale of HTC government bonds in July generated a gain of EUR 62 million and around 70 basis points of capital during this quarter. On the Pollen transaction, the portfolio disposal generated around 20 basis points in Q3, with more to come by year-end. The total impact is expected to reach around 100 basis points by 2028 through lower calendar provisioning and lower RWAs. We have also agreed a forward flow agreement in Spain. This gives us the right, but not the obligation, to sell LPIs to Pollen at their carrying value. To be clear, we have no obligation to sell.
When our capital ratios return to a suitable level, we will be able to keep all of our upside on the Spanish LPIs if any. This transaction also gives us a sustainable and profitable business model in Spain, where the past due ratio is expected to decrease by a factor of 10. We have created around 170 basis points of capital through management actions. Are we happy we had to do this? Let me move to the next slides. I will not read the comments, but you see what Moody's has to say about our capital position. We have pointed out very clearly in our first half communication that there are significant uncertainties on our going concern status. This has required us to submit a Capital Conservation Plan. The sale of Italian government bonds and the Pollen transactions were only a part of the plan.
The plan was finally approved on the October 1st by Bank of Italy, and one of its key pillars is the pursuit of a strategic partnership. The exclusivity granted to Cerberus is to be seen in this framework. If we go to next slides, the need to move quickly is driven by the impact of calendar provisioning we have already disclosed in our first half numbers. As you can see on this slide, we expect a steep increase in calendar provisioning in 2027, starting from Q2, and a further increase in 2028. Our Capital Conservation Plan project calendar provisioning of around EUR 550 million, which is almost equal to our current CET1 capital level. Of course, the Capital Conservation Plan envisages execution risk. This underlines the need for us to execute on our Capital Conservation Plan.
If we move to next slide. On e of the reasons for the difficulty of managing calendar provisioning organically is that LPIs stay on our balance sheet much longer than the two to three years in which calendar provisioning fully kicks in. As this graph shows, the seven-year collection rate is now less than half of what it was in 2010 or 2014. This is due to increased exposure to public administration as opposed to NHS, as well as ordinary legal actions and international expansion. For clarity, when we actually collect LPIs, we are still collecting around 80% in line with our historical average, but we are collecting less often. So, why am I optimistic? If we move to the next slide. While we face back book challenges that we are working to address, there are more encouraging signs on our front book.
So far, we have collected 97% of our 2025 volumes and almost 80% of our 2026 volumes. We collect capital in a way that means new capital contribution to calendar should be manageable. Not only this, but the new business is financially attractive. Excluding the effect of LPIs, our nine months production has generated an IRR or yield, if you wish, of circa 7%. This compares to around 6% in the first half. Any LPI collection will only provide additional upside. Go to slide 24. This slide shows the IRR on new origination in more detail. Returns are now being generated by the discounts to the invoice face value at the purchase date. This is obviously a big change to periods when state entities had payment times well above one year. LPI collection, which typically happens much later and comes at a non-negligible cost, provides further upside.
Putting the pieces together, we provide financing against receivables to public entities short-term with an attractive 7% + yield, without including the effect of LPI. This is a good business. Let me conclude now. We have solid Payments and Securities Services business that continues to perform well. Our Factoring & Lending business is impacted by our planned de-risking and negative court rulings, and the front book is performing well. We are focused on executing our Capital Conservation Plan and the management actions we have already taken to protect our capital ratios. As you will understand, we cannot say anything more on the discussions with Cerberus at this stage, and we will provide any update in due course. Thank you very much for your attention, and let me now open the line for questions.
We will now begin the question-and-answer session. To ask a question, you may press star then one on your touchtone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star then two. The first question comes from Giovanni Razzoli with Deutsche Bank. Please go ahead.
Good afternoon to everybody. Thank you for taking my questions. I have a number. I apologize if some of them are already covered by the presentation, but the press release distribution was a little bit late. I was wondering whether you can share with us, or if I interpret correctly, it is already in the presentation, what was the performance in terms of collection for LPIs and recovery fees in the nine months compared with 2026, compared with 2025? On the calendar provisioning, if I look at slide 21, you are showing us clearly an acceleration of the calendar provisioning 27 after EUR 390 million when compared with the maximum curve of EUR 660 million. I was wondering what kind of assumptions have you made here in terms of collection or disposal of the receivable back to client.
I am wondering why it is not possible to accelerate the rundown of the calendar provisioning, so to say, accelerating the put-back of the receivable which are generating the calendar provisioning to the clients. Second question is on Poland. You have mentioned that the increase in the UTP when compared to year-end is mostly related to the classification of some position in Poland. But if I am not mistaken, there has been a sentence of the Supreme Court in the country which state that those accounts cannot default. I struggle to see a credit risk here, if I am not mistaken, and then wondering whether a different classification of those position could be applicable and what could be the benefit in terms of capital consumption.
On Poland, if I am not wrong, in the past, you have mentioned that you would be considering the disposal of part of the Polish business. Can you remind us the scope of this portfolio and at what stage are we in the overall process? Another two questions, I think are relatively short. The transaction with Cerberus, which you have now confirmed, you have an exclusivity agreement with them, which seems a little bit of a change when compared with the previous idea of the board, which seems to prioritize a securitization when compared with the involvement of an external partner. I was wondering what has drove the change in this strategy, whether you now see a securitization more difficult to be implemented. In case there is no agreement with Cerberus at the end, what are the contingency plans to cope with the calendar provisioning effect?
Last point, I was wondering whether the transaction in Spain that you have recently announced, you show us the economics. I was wondering, I am a little bit surprised, to be fair, to see that, as far as I understand, Spain has a relatively short period of payments, also on the back of the several liquidity injections which have been put by the government. So, I was wondering why this transaction will not impact the profitability with the forward flow agreement. Clearly, you have the right to retain future LPIs, but on the back of a relatively short period of time in terms of DSO in the country, I would have expected that this effect would have been much lower. Thank you.
Apologize that we uploaded. Thank you, Giovanni. Let me apologize that we uploaded the press release a bit late. So I will try to be as complete as I can. I do not think we normally give details on the overall LPI collection, I would say a few things. The first one is that if you look at the overall collection, including the transactions we did in Italy and the transaction we did in Spain, this was probably the best year in terms of LPI cash-in, although through some specific transaction. If you look at the underlying performance, the year was not great. I think I have shown that our collection rates have gone down consistently over the last few years. It is one of the few slides that we have included, so that explains part of the performance.
It is also true that we had to recreate the overall design of the factoring business, given we are redesigning it, given the criticalities that Bank of Italy identified in its inspection report. So we can certainly do better, and we will do better, but we cannot ignore recent history. You also understand that when you have a high percentage or very high percentage of negative sentences, it becomes very difficult to go and transact. On the calendar provisioning, we are assuming collection rates in line with recent performance. We are not assuming any additional extraordinary transaction. So that is what we can do. You are asking me, can we accelerate?
If I take you on page 21 of the presentation, I show what was the calendar in first half, EUR 141 million, what was the calendar in nine months, which was EUR 148 million. Then we have a target, so it went up by EUR 7 million in a quarter. Now the target in the Capital Conservation Plan is to take it down by around EUR 40 million. So we have significant execution risk. That is the way I would characterize it. On Poland, we think the current reclassification reflects properly the status of our internal policies, reflects correctly also the risk. You mentioned Supreme Court case, which reflects one specific hospital and does not apply to every single case. There are a few law proposals already drafted in Poland which actually say that public hospital can restructure.
Now, if you ask me what is better, can they restructure or can they not restructure, I do not know what is the best answer. Because if you have a hospital that cannot restructure and does not have the money, what happens? I do not have the answer for you, but certainly as part of our remediation plan for Bank of Italy , it is something that we are looking in great detail at. On Poland, yes, you remember correctly. I said we are reducing the impact of the factoring-like product, which was reclassified as past due with the 2025 annual report. So we already put it in a substantial runoff. Of course, it is not the optimal solution. We would prefer to do that business without having the past due, which means to identify a partner which may take, for instance, 51% of that small portfolio.
The reduction in the FLP is already in our projection, so there is no upside. The upside would be if we can find the partner and we can increase that book once again. On Cerberus, of course, I do not comment more on this specific deal. I do not think the board ever said, to my recollection, that there was a priority for one solution versus the other. Actually, I have said consistently over the last few months that the need for a partner, whatever it means, is needed to offset the impact of past due and calendar provisioning on the new production and on the back book. We write, I think in the press release, that there is no certainty at this stage of any conclusion around the discussions with Cerberus. In the press release, there is the list of other actions that we may undertake.
It is important, and it was in the speech of Luigi, that the number of actions that we can undertake are reducing in number and their likelihood is decreasing. On Spain, you are right, DSO are very short. DSO are referred generally to capital. So the transaction with Pollen in Spain had to do with the LPIs, and the collection times of LPIs are substantially longer, and the amount we collect is definitely very far from 100%.
I heard just—
The next question comes from Tommaso Nieddu with Kepler Cheuvreux. Please go ahead.
Hello, and thank you a lot for taking my questions. I have just a couple. The first one is on the discussions with Cerberus. Just wondering whether a capital injection alone would be sufficient to address the long-term calendar provisioning issue, or would you still need or look to a structured solution like regarding forward flow agreements in Italy as well? Then the second question is on the ongoing capital optimization and the potential strategic review. Just trying to understand how you think about your stake in Generalfinance. Is it still considered strategic, or could it be monetized as part of the broader capital plan? Thank you.
Thank you, Tommaso. On Cerberus, I was looking at my Q&A list to find the scripted answer. I couldn't find it, but as I said, we don't comment further on that one and any related actions. On Generalfinance, we did not discuss it recently or not recently. To be clear, it's carried in our capital at market value, so selling it would not create substantial capital in any case.
Okay, thank you.
The next question comes from Camilla Cotta Ramusino with Anima Sgr. Please go ahead.
Hello, good evening. Thank you for taking my question. I have a question about the senior preferred with the first call on 2027. I see on the slide that your MREL ratio is above the requirement. Do you have an idea of the impact of the potential call of the senior? Are you planning to issue new MREL-eligible senior prior to the call in 2027? Do you expect the need for a formal regulatory approval to exercise the call? In that case, are there any discussions? Thank you.
Thank you, Camilla. The reality is that at the call date, the senior will not have any capital content, so to keep it on balance sheet would not create any benefit for us. I would not expect anything different from what is natural from a financial perspective. On what we will do in the future, we will see again in the press release. We mentioned that as part of the Capital Conservation Plan, issuances may be contemplated. Let me stress, however, that it's important that issuances must come as part of an overall strategy of reinforcement.
The next question comes from Domenico Maggio with Jefferies. Please go ahead.
Hi, thank you. Good evening. I wanted to ask, first question, how do you balance the interest of the regulator and the interest of existing shareholder? I mean, the regulator is following you in your Capital Conservation Plan, which needs some capital action that might be dilutive for existing shareholder, and the existing shareholder clearly dislike them. I am just curious to understand better how do you balance that, and whether, I mean, looking at certain slide, like slide 20, I wonder whether you are trying to basically get existing shareholder on board with some action that might be dilutive for them. Then, moving away from this, maybe touching on the question from Camilla, what happen if you end up in a MREL plus buffer breach? I mean, do you need to negotiate with EBA or just keep on negotiating with BOI for any plan to return above?
Yeah, that would be my two question.
Thank you, Domenico. You know, I am the CEO of a bank, and therefore I try to respect the banking regulator. It is like if you are a football player and you have to respect the rules given by the referee, then you give the best on the pitch, okay? For the interest of your team, and my team are my stakeholders. That is the way I would answer to you. But there are rules, and if we want to play, we respect the rules. On the breach of MREL, listen, we have breached already capital ratios. We have had to present Capital Conservation Plan. We hope not to breach again capital ratios before we have found a solution.
Okay. On the, I guess you are going to continue to negotiate. I mean, if there is a breach, it would be with the BOI that you need to discuss, not the EBA or anyone else.
Yeah. Let me remind you also that, for instance, Bank of Italy reduced our MREL requirements recently. We are also benefiting from that reduction in MREL requirements. I think you should read these in a very balanced and constructive way.
Thank you. Appreciate it. If I can just follow up with one small one. On the securitization, I mean, you touched on earlier on, we did not get any update and some time has passed. Why is this the case? Did any other banks do an SRT on similar exposure recently? Any competitor, so on and so forth?
Yeah. You did not get an update. You got an update regarding the fact that we are in exclusivity talks with Cerberus.
Yeah.
Regarding your question, I believe there was a press release from one of our competitors in Italy that did a smaller deal. Of course, a smaller deal is probably easier to execute. You can select differently the portfolio, maybe you have less or fewer negative sentences. But yes, I think they did a press release.
Do you know the size by any chance?
I haven't captured that.
Okay. Thank you. Thank you very much. Very helpful.
The next question comes from Sharada Patel with Citi. Please go ahead.
Hi. I have four questions. The first is in the press release today, you say that a change in assumptions mean that the capital breach may come earlier than 2028, which was what was previously expected. What specifically are those changes in assumptions? The second question's on deposit movements. You talk about an exit of a single large counterparty. Was that the one that was seen in the second quarter, or have there been any other sort of movements in the third quarter? On the kind of point of issuance of Tier two or preferred senior, last quarter when we asked you said that you would come back from summer holidays and kind of assess the market and see. I guess my question is, since then we've had a significant sell-off across the market and in your name specifically.
Just wanted to know what you are waiting for and how you think about issuance. Then similarly on the securitization, you also say that that would require Bank of Italy approval. Is that something that you think could make the situation a little bit more complex, or why is that holding you back somewhat? Just thinking thoughts about why you are waiting there as well, please. Thank you.
Okay. Thank you for the question. I am trying to find the English version of the press release, but we list the factors very clearly in the press release. By the way, the list of factors is not new because we had it in the first half reports and in the first half press release as well. I think it is as detailed as we can be at this stage. Of course, we do not have a number for each and every single one of those elements, otherwise it would be in our numbers. But it is something that the bank has been asked to look at as part of the Bank of Italy inspection report.
There were obviously a broad range of factors mentioned, so there is nothing—
[inaudible]
—specifically or—
It is a very broad range of factors. On the single name, yes, it was always the same, i.e., with only 69% loan-to-deposit ratio, I would not add too much on liquidity. Tier two, you are right, there has been a very significant sell-off in the market. I have met with several of my credit holders, and there is appetite, but equally, I have been told maybe you should wait until it is financially rational to do that. We are monitoring. We have an EMTN approved. We are waiting for the right moment when it comes. On the securitization, I would answer to you in the same way. We announced that we are in exclusivity on a potentially bigger perimeter. But certainly, the opinion from the regulator on deconsolidation is important, and that is why it is mentioned in the press release.
Sorry, just getting back onto that point about Bank of Italy approval on the securitization. How do you think, how do you assess that? Is that a hurdle to completing the securitization?
It is a precondition, I would say, of the securitization. You can announce it, but you cannot achieve synthetic risk transfer until the approval has arrived, if it arrives. Because we are at the moment exploring other venues, it is difficult to assess at this stage.
Okay. Thank you.
This concludes our question and answer session. I would like to turn the conference back over to Giuseppe Sica for any closing remarks.
Thank you, everyone, for your time, and we will speak at the next conference call. Thank you.
The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.